Selectes References

Virology

Head of Institute:
Prof. Dr. med. Klaus Überla

Selected References

  • Zilker, C., Kozlova, D., Sokolova, V., Yan, H., Epple, M., Überla, K., Temchura, V. (2017). Nanoparticle-based B-cell targeting vaccines: Tailoring of humoral immune responses by functionalization with different TLR-ligands. Nanomedicine, 13: 173-182.
  • Kolenbrander, A., Grewe, B., Nemazee, D., Überla, K., Temchura, V. (2018). Generation of T-follicular helper cells in vitro: requirement for BCR cross-linking and cognate B- and T-cell interaction. Immunology, 153: 214-224.
  • Elsayed, H., Nabi, G., McKinstry, W.J., Khoo, K.K., Mak, J., Salazar, A.M., Tenbusch, M., Temchura, V., Überla, K. (2018). Intrastructural Help: Harnessing T-Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines. J Virol, 92: e00141-18.
  • Nganou-Makamdop, K., Billingsley, J.M., Yaffe, Z., O'Connor, G., Tharp, G.K., Ransier, A., Laboune, F., Matus-Nicodemos, R., Lerner, A., Gharu, L., Robertson, J.M., Ford, M.L., Schlapschy, M., Kuhn, N., Lensch, A., Lifson, J., Nason, M., Skerra, A., Schreiber, G., Bosinger, S.E., Douek, D.C. (2018). Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication. PLoS Pathog, 14(8): e1007246.
  • Kityo, C., Makamdop, K.N., Rothenberger, M., Chipman, J.G., Hoskuldsson, T., Beilman, G.J., Grzywacz, B., Mugyenyi, P., Ssali, F., Akondy, R.S., Anderson, J., Schmidt, T.E., Reimann, T., Callisto, S.P., Schoephoerster, J., Schuster, J., Muloma, P., Ssengendo, P., Moysi, E., Petrovas, C., Lanciotti, R., Zhang, L., Arévalo, M.T., Rodriguez, B., Ross, T.M., Trautmann, L., Sekaly, R.P., Lederman, M.M., Koup, R.A., Ahmed, R., Reilly, C., Douek, D.C., Schacker, T.W. (2018). Lymphoid tissue fibrosis is associated with impaired vaccine responses. J Clin Invest, 128: 2763-2773.